Goldman Sachs’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-268
| Closed | -$30K | – | 4364 |
|
|
2019
Q3 | $30K | Buy |
268
+223
| +496% | +$25K | ﹤0.01% | 4165 |
|
|
2019
Q2 | $6K | Hold |
45
| – | – | ﹤0.01% | 4159 |
|
|
2019
Q1 | $8K | Buy |
+45
| New | +$8K | ﹤0.01% | 4155 |
|
|
2017
Q3 | – | Sell |
-129
| Closed | -$639K | – | 4407 |
|
|
2017
Q2 | $639K | Buy |
129
+127
| +6,350% | +$629K | ﹤0.01% | 3391 |
|
|
2017
Q1 | $9K | Buy |
+2
| New | +$9K | ﹤0.01% | 4373 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | -$48K | – | 4559 |
|
|
2016
Q3 | $48K | Buy |
3
+2
| +200% | +$32K | ﹤0.01% | 4317 |
|
|
2016
Q2 | $20K | Sell |
1
-11
| -92% | -$220K | ﹤0.01% | 4409 |
|
|
2016
Q1 | $249K | Buy |
12
+9
| +300% | +$187K | ﹤0.01% | 3643 |
|
|
2015
Q4 | $57K | Buy |
+3
| New | +$57K | ﹤0.01% | 4148 |
|
|
2015
Q2 | – | Sell |
-3
| Closed | -$55K | – | 4741 |
|
|
2015
Q1 | $55K | Buy |
3
+2
| +200% | +$36.7K | ﹤0.01% | 4271 |
|
|
2014
Q4 | $19K | Sell |
1
-4
| -80% | -$76K | ﹤0.01% | 4488 |
|
|
2014
Q3 | $84K | Sell |
5
-1
| -17% | -$16.8K | ﹤0.01% | 4274 |
|
|
2014
Q2 | $86K | Hold |
6
| – | – | ﹤0.01% | 4217 |
|
|
2014
Q1 | $129K | Buy |
6
+2
| +50% | +$43K | ﹤0.01% | 4088 |
|
|
2013
Q4 | $50K | Buy |
+4
| New | +$50K | ﹤0.01% | 4175 |
|